| References |
Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol. 2014 Jun;71(6):785-93. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, AkamatsuT, et al. High serum IgG4 concentrations in patients with scle-rosing pancreatitis. N Engl J Med. 2001;344:732-8. Perugino, C.A., Stone, J.H. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16, 702-714 (2020). Deshpande V, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep;25(9):1181-92. Rispens, T., Huijbers, M.G. The unique properties of IgG4 and its roles in health and disease. Nat Rev Immunol 23, 763-778 (2023). Sasaki T, Akiyama M, Kaneko Y, Yasuoka H, Suzuki K, Yamaoka K, Takeuchi T. Risk factors of relapse following glucocorticoid tapering in IgG4-related disease. Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):186-189. Epub 2018 May 24. PMID: 29846165. Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015 Jan;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907. Epub 2014 Mar 20. PMID: 24651618. Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot L, Sedat J, Fontaine D, Bourg V, Martis N, Lebrun-Frenay C. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review. Neurol Neuroimmunol Neuroinflamm. 2019 May 7;6(4). Peter, N., Khooshabeh, R. & Soilleux, E. IgG4 orbitopathy: unravelling a multisystem diagnostic challenge. Eye 26, 1150-1151 (2012). Gan, L., Luo, X., Fei, Y. et al. Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients. BMC Ophthalmol 21, 447 (2021). |